Celltrion has seen the launch of its first labor union since its founding. According to the bio industry on the 1st, the ...

Workers at Celltrion, a Korean biopharmaceutical firm, launched a labor union for the first time in the company's history, ...

South Korean pharmaceutical f company Celltrion on Wednesday reported first-quarter sales of $790 million, up 36% from the year before.

Celltrion announced that it will implement measures to enhance shareholder value and strengthen responsible management in line with the completion of ...

Celltrion said Wednesday it expects to log record quarterly earnings of 1.28 trillion won ($887 million) in revenue and 472.2 billion won in operating profit in the fourth quarter this year thanks to ...

TORONTO, Ontario, November 27, 2025--(BUSINESS WIRE)--Celltrion, Inc. today announced that Health Canada has approved Eydenzelt ®, a biosimilar referencing Eylea ® (aflibercept 2mg), in both vial and ...

Celltrion has obtained the Food and Drug Administration’s clearance for a new presentation of Steqeyma (ustekinumab-stba), a biosimilar to Stelara (ustekinumab), in a 45mg/0.5ml solution in a ...

Celltrion, a South Korean biopharma, said that despite receiving Complete Response Letters from the FDA, it remains optimistic it will get U.S. approval for its two biosimilar drugs, Rituxan and ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The logo of Celltrion is seen at the company's headquarters in Incheon SEOUL (Reuters) - South Korea's Celltrion Inc ...

Celltrion said Tuesday it will invest 1.23 trillion won ($820 million) to build two new plants in Songdo, Incheon, bolstering its capacity by 180,000 liters amid the increasing global demand.

SEOUL (Reuters) - South Korea's Celltrion Inc said on Monday its experimental treatment of COVID-19 demonstrated an up to 100-fold reduction in viral load of the disease in animal testing, saying it ...